18 USD
+0.84 (+4.9%)
17.92 USD
-0.08 (-0.44%)
ChartMill assigns a Buy % Consensus number of 88% to DNLI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 32.23. This target is 79.07% above the current price.
DNLI was analyzed by 25 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about DNLI.
In the previous month the buy percentage consensus was at a similar level.
DNLI was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-19 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-08 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-07 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-05-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-05 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2025-03-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-11 | Deutsche Bank | Initiate | Buy |
| 2025-01-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-01-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-07 | Baird | Initiate | Outperform |
| 2025-01-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-03 | William Blair | Initiate | Outperform |
| 2024-12-16 | Stifel | Upgrade | Hold -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-01 | Jefferies | Maintains | Buy -> Buy |
| 2024-10-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-10 | Raymond James | Reiterate | Market Perform |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-04 | B of A Securities | Maintains | Buy -> Buy |
| 2024-09-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-08-02 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-10 | JP Morgan | Maintains | Overweight -> Overweight |
DENALI THERAPEUTICS INC / DNLI FAQ
What is the average price target for DENALI THERAPEUTICS INC (DNLI) stock?
25 analysts have analysed DNLI and the average price target is 32.23 USD. This implies a price increase of 79.07% is expected in the next year compared to the current price of 18.
What is the consensus rating for DNLI stock?
The consensus rating for DENALI THERAPEUTICS INC (DNLI) is 88 / 100 . This indicates that analysts generally have a positive outlook on the stock.